BGMS - Cyclacel Pharmaceuticals, Inc.
0.95
-0.010 -1.063%
Share volume: 19,112
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.96
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 11-12-2024 | 05-14-2025 | 08-14-2025 | 11-13-2025 | |
| Cash flow financing | -79.000 K | 0.000 | 3.646 M | 1.880 M | -3.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -562.000 K | 0.000 | 399.000 K | 0.000 | 0.000 | |
| Net income | -2.946 M | -1.957 M | -81.000 K | -1.318 M | -988.000 K | |
| Depreciation | 2.000 K | 0.000 | 0.000 | 1.000 K | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -580.000 K | 0.000 | 313.000 K | 825.000 K | -437.000 K |